Biotech · Private company
Rondo Therapeutics
Track this companyFree. Adds Rondo Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- PembrolizumabPhase 1 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
- RNDO-564Phase 1 · Non Small Cell Lung CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- A Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4PHASE1 · ENROLLING_BY_INVITATION · started Nov 17, 2025ClinicalTrials.gov NCT07218003 · fetched Nov 12, 2026